Armata Pharmaceuticals Inc (ARMP)vsRevolution Medicines Inc (RVMD)
ARMP
Armata Pharmaceuticals Inc
$7.50
-2.47%
HEALTHCARE · Cap: $290.75M
RVMD
Revolution Medicines Inc
$155.69
+3.11%
HEALTHCARE · Cap: $32.71B
Smart Verdict
WallStSmart Research — data-driven comparison
Armata Pharmaceuticals Inc generates 601% more annual revenue ($5.20M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs 0.0%. ARMP earns a higher WallStSmart Score of 28/100 (F).
ARMP
Avoid28
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+79.8%
Fair Value
$39.70
Current Price
$7.50
$32.20 discount
Intrinsic value data unavailable for RVMD.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 60.7% year-over-year
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -3439.0% — below average capital efficiency
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : ARMP
The strongest argument for ARMP centers on Revenue Growth, Debt/Equity. Revenue growth of 60.7% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : ARMP
The primary concerns for ARMP are EPS Growth, Market Cap, Profit Margin.
Bear Case : RVMD
The primary concerns for RVMD are EPS Growth, Profit Margin, Operating Margin.
Key Dynamics to Monitor
ARMP profiles as a hypergrowth stock while RVMD is a value play — different risk/reward profiles.
RVMD carries more volatility with a beta of 1.41 — expect wider price swings.
ARMP is growing revenue faster at 60.7% — sustainability is the question.
ARMP generates stronger free cash flow (-6M), providing more financial flexibility.
Bottom Line
ARMP scores higher overall (28/100 vs 24/100) and 60.7% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Armata Pharmaceuticals Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Armata Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of specific bacteriophage therapies for the treatment of antibiotic-resistant infections worldwide. The company is headquartered in Marina del Rey, California.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?